Beyond the hype: What AI really means for biotech
California's pioneering R&D agency is at a crossroads
Justice Department sues to break up Live Nation and Ticketmaster
Guest opinion: Don't break the life-sciences industry
Why this San Francisco job-search company is going fully remote
Daily Digest: VC giant opens new office; S.F. coffee brand's next CEO
How AI is working — and how it isn't — at UCSF
Bay Area VC giant establishing first D.C. office
An overlooked program is deploying billions to businesses
The remote work landscape is shifting, but a key metric isn't budging
Who needs a big merger? Peninsula biotech sets out to raise $1 billion
The Harrison in South Beach San Francisco
Historic Fisherman's Wharf restaurants sue S.F. over street conditions
A Covid-era option for bankruptcy filings is about to expire
Massive East Bay office complex sells for $150 million
The National Observer: Investor homebuying moves up
The 'lock-in' effect is hitting homebuyers. It may get worse.
Value of San Francisco trophy asset a testament to city's office reset
Biogen to pay $1.2B for Peninsula startup with kidney disease drug
Daily Digest: Company nixes Dogpatch couriers; Walmart's local cuts
Apartment market cools with record amount of new supply wrapping up
Here’s how much Zoskland made from selling its Coliseum stake
Biotech zeroing in on ulcerative colitis rakes in hundreds of millions
Here's what Chase's Jamie Dimon thinks about AI
Once-popular North Beach restaurant finds new operator
Doctor's office, heal thyself
East Bay condos could spring up near BART rail extension
Workers with learning disabilities face stigmas in the workplace
- 1 of 371
- Next